Register Login

Abiopharma

  • Home
  • About
  • Newsroom
  • Company List
  • Events
  • Automated Tools
  • Contact

News list

HIMS & HERS HEALTH, INC. (HIMS)

  • Business News
  • Aug. 26, 2026, 17:03 UTC
  • 7
  • 1 comments

Hims & Hers Health (NYSE: HIMS) Stock Plunges 14% Following Major FTC Lawsuit Over Privacy & Billing; Hagens Berman Investigates Corporate Compliance and Investor Ramifications

Market reaction Comment Full text

DULUTH HOLDINGS INC. (DLTH)

  • Business News
  • Aug. 26, 2026, 17:02 UTC
  • 7
  • 1 comments

What Underwear Should You Buy for Fall? Duluth Trading Shares First-Layer Essentials for Back to Campus and Back to Work

Market reaction Comment Full text

VERTIV HOLDINGS CO (VRT)

  • Business News
  • Aug. 26, 2026, 17:02 UTC
  • 7
  • 1 comments

VRT Alert: HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Encourages Vertiv Holdings Co (NYSE: VRT) Investors with Significant Losses to Contact Firm

Market reaction Comment Full text

FRONTIER NUCLEAR & MINERALS INC. (FNUC)

  • Business News
  • Aug. 26, 2026, 17:01 UTC
  • 2
  • 1 comments

Frontier Nuclear and Minerals Announces 2026 Annual General Meeting Results

Market reaction Comment Full text

WORKSPORT LTD (WKSP)

  • SEC News
  • Aug. 26, 2026, 17:00 UTC
  • 1
  • 1 comments

(99% Positive) WORKSPORT LTD (WKSP) Reports Q3 2026 Financial Results

Comment Full text

METROPOLITAN BANK HOLDING CORP. (MCB)

  • Business News
  • Aug. 26, 2026, 17:00 UTC
  • 2
  • 1 comments

MCB Alert: HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Encourages Metropolitan Bank Holding Corp. (NYSE: MCB) Investors with Significant Losses to Contact Firm

Market reaction Comment Full text

CYCURION, INC. (CYCU)

  • Business News
  • Aug. 26, 2026, 17:00 UTC
  • 2
  • 1 comments

Cycurion: 1-for-8 Reverse Split Backed by Stronger Fundamentals

Market reaction Comment Full text

Revolution Medicines Inc (RVMDW)

  • Business News
  • Aug. 26, 2026, 16:59 UTC
  • 2
  • 1 comments

U.S. FDA Approves Revolution Medicines’ RASONQUE™ (daraxonrasib), the First Broad RAS-Targeted Medicine in Metastatic Pancreatic Cancer

Market reaction Comment Full text

REVOLUTION MEDICINES, INC. (RVMD)

  • Business News
  • Aug. 26, 2026, 16:59 UTC
  • 2
  • 1 comments

U.S. FDA Approves Revolution Medicines’ RASONQUE™ (daraxonrasib), the First Broad RAS-Targeted Medicine in Metastatic Pancreatic Cancer

Market reaction Comment Full text

SMURFIT WESTROCK PLC (SW)

  • Business News
  • Aug. 26, 2026, 16:50 UTC
  • 2
  • 1 comments

Sodexo réalise une émission obligataire d’un montant de 1 100 000 000 d’euros

Market reaction Comment Full text

SMURFIT WESTROCK PLC (SW)

  • Business News
  • Aug. 26, 2026, 16:50 UTC
  • 2
  • 1 comments

Sodexo completes a euro-denominated bond issuance of EUR 1,100,000,000

Market reaction Comment Full text

PINNACLE BANCSHARES, INC. (PCLB)

  • Business News
  • Aug. 26, 2026, 16:49 UTC
  • 1
  • 1 comments

Pinnacle Bancshares Declares $0.27 Per Share Quarterly Cash Dividend

Market reaction Comment Full text

HUB GROUP, INC. (HUBG)

  • Business News
  • Aug. 26, 2026, 16:48 UTC
  • 1
  • 1 comments

DEADLINE APPROACHING: Berger Montague Advises Hub Group, Inc. (NASDAQ: HUBG) Investors to Inquire About a Securities Fraud Class Action by August 28, 2026

Market reaction Comment Full text

BANK OF AMERICA CORP /DE/ (BAC)

  • SEC News
  • Aug. 26, 2026, 16:46 UTC
  • 1
  • 0 comments

New Form 424B2 - BANK OF AMERICA CORP /DE/ <b>Filed:</b> 2026-08-26 <b>AccNo:</b> 0001918704-26-024930 <b>Size:</b> 1 MB

Comment Full text

GOLDMAN SACHS GROUP INC (GS)

  • SEC News
  • Aug. 26, 2026, 16:46 UTC
  • 1
  • 0 comments

New Form 424B2 - GOLDMAN SACHS GROUP INC <b>Filed:</b> 2026-08-26 <b>AccNo:</b> 0001193125-26-368008 <b>Size:</b> 682 KB

Comment Full text
  • Previous
  • 1387
  • 1388
  • 1389
  • 1390
  • 1391
  • Next

Search

News categories

  • Technical Exchange News(14734)
  • Event(6229)
  • SEC News(395097)
  • FDA Approval(10304)
  • Company Report(721)
  • Business News(240741)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin